Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surveillance of catheter-associated urinary tract infections at an Australian tertiary hospital, 2024-2025.

Infection, disease & health·2026
Same author

Effectiveness of oral care for the prevention of non-ventilator hospital-acquired pneumonia (HAPPEN): a multicentre, stepped-wedge, cluster-randomised trial in Australia.

The Lancet. Infectious diseases·2026
Same author

Schistosomiasis vaccine SchistoShield® induces functional immune memory responses in US and African populations.

NPJ vaccines·2026
Same author

Room-return ventilation and N95 respirator policies for reducing airborne pathogen exposure on hospital wards.

The Journal of hospital infection·2026
Same author

Systems Thinking Tools to Shift Stakeholder Engagement in Food and Nutrition Insecurity.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2026
Same author

Culturally responsive nutrition interventions addressing chronic conditions in Latino adults living in the United States: a scoping review.

BMC nutrition·2026

Related Experiment Video

Updated: Jun 6, 2025

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

11.7K

Vaccine value profile for schistosomiasis.

Gavin Yamey1, Kaci Kennedy McDade1, Roy M Anderson2

  • 1Duke Global Health Institute, Duke University, Durham, NC, United States.

Vaccine
|November 26, 2024
PubMed
Summary

Schistosomiasis, a parasitic flatworm disease, affects millions globally, primarily in poor, rural areas. This Vaccine Value Profile assesses the potential value of new vaccines to combat this neglected tropical disease.

Keywords:
Neglected tropical diseasesParasitic infectionSchistosomiasisVaccine value

More Related Videos

Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum
07:37

Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum

Published on: May 22, 2018

7.9K
High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
10:38

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

Published on: July 17, 2014

23.0K

Related Experiment Videos

Last Updated: Jun 6, 2025

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

11.7K
Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum
07:37

Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum

Published on: May 22, 2018

7.9K
High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
10:38

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

Published on: July 17, 2014

23.0K

Area of Science:

  • Neglected tropical diseases
  • Parasitology
  • Vaccinology

Background:

  • Schistosomiasis is a debilitating parasitic disease caused by Schistosoma flatworms, affecting over 230 million people worldwide.
  • Infection occurs through skin penetration by parasite larvae in contaminated water, disproportionately impacting poor, rural communities.
  • Limited access to safe water and sanitation exacerbates the risk and prevalence of schistosomiasis.

Purpose of the Study:

  • To conduct a holistic assessment of available data for schistosomiasis vaccines.
  • To inform the potential public health, economic, and societal value of pipeline vaccines and vaccine-like products.
  • To identify current research and knowledge gaps in schistosomiasis vaccine development.

Main Methods:

  • Development of a Vaccine Value Profile (VVP) for schistosomiasis.
  • Utilized a working group of subject matter experts from diverse sectors.
  • Information gathering based exclusively on existing, publicly available data.

Main Results:

  • The VVP provides a comprehensive overview of schistosomiasis vaccine-related information.
  • Identified key areas requiring further research and data collection.
  • Highlighted the potential value of vaccines in addressing a major global health challenge.

Conclusions:

  • A strategic approach is needed to evaluate and advance schistosomiasis vaccine development.
  • Understanding the multifaceted value of vaccines is crucial for effective public health interventions.
  • Continued research and expert collaboration are essential to bridge knowledge gaps and accelerate vaccine accessibility.